1149752-51-1 Usage
General Description
"(R)-N-((S)-1-(5-fluoropyridin-2-yl)ethyl)-2-Methylpropane-2-sulfinaMide" is a chemical compound that consists of a chiral center and a sulfonamide group. It is a white to off-white solid that is used in pharmaceutical research and development. (R)-N-((S)-1-(5-fluoropyridin-2-yl)ethyl)-2-Methylpropane-2-sulfinaMide is a potential candidate for the treatment of various medical conditions, particularly in the field of neuroscience and oncology. It has shown promising pharmacological properties in preclinical studies, making it a subject of interest in drug discovery. The unique structure of "(R)-N-((S)-1-(5-fluoropyridin-2-yl)ethyl)-2-Methylpropane-2-sulfinaMide" makes it a valuable building block for the synthesis of new chemical entities with potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1149752-51-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,4,9,7,5 and 2 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1149752-51:
(9*1)+(8*1)+(7*4)+(6*9)+(5*7)+(4*5)+(3*2)+(2*5)+(1*1)=171
171 % 10 = 1
So 1149752-51-1 is a valid CAS Registry Number.
1149752-51-1Relevant articles and documents
P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN
-
Paragraph 120; 0124, (2018/02/04)
The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor s
P2X3 RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN
-
Page/Page column 50-51, (2010/11/18)
The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X
P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN
-
Page/Page column 140, (2009/06/27)
The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor subunit modulator.